COVID-19 presentation and outcomes in patients with inflammatory rheumatic and musculoskeletal diseases receiving IL6-receptor antagonists prior to SARS-CoV-2 infection.
Comarmond C, Drumez E, Labreuche J, Hachulla E, Thomas T, Flipo RM, Seror R, Avouac J, Balandraud N, Desbarbieux R, Felten R, Gilson M, Guyot MH, Hittinger-Roux A, Pham T, Renard M, Roux N, Sobanski V, Tournadre A, Richez C, Cacoub P; FAI2 R/SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors.
Comarmond C, et al. Among authors: drumez e.
J Transl Autoimmun. 2023 Jan 14;6:100190. doi: 10.1016/j.jtauto.2023.100190. eCollection 2023.
J Transl Autoimmun. 2023.
PMID: 36684808
Free PMC article.